Quality boost for pills; Free fill for cancer candidate;

> Pill quality may get a boost from scientists at the University of Maryland, who are using near-infrared spectroscopy to study how pills dissolve in the body. Article

> Under its Fillanthropy Program, Formatech will donate services required to aseptically fill and finish one lot of ViroMed's VM206 vaccine targeting breast cancer to support upcoming clinical trials. Announcement

> Contract researcher MakroCare, in collaboration with Advanced Drug Development Services, will offer pharmacovigilance and drug safety services. Release

> Bulk drug manufacturer Unimark Remedies has plans to launch some 30 oncology and critical-care products and offer radiation, chemotherapy and oncology-specialized pharmacies under one roof. Article

> India is about to kick off its Focus Pharmacovigilance program to study a dozen "controversial drugs," including certain non-steroidal anti-inflammatories, anti-depressants and nasal decongestants, which are banned or considered risks for adverse effects by other nations. Article

Suggested Articles

Dr. Reddy’s says it has been told the FDA will not take regulatory action at its sterile formulations plant in Duvvada, Visakhapatnam.

The end is near for a GlaxoSmithKline OTC plant in Pennsylvania and its 260 employees. In fact, it has a date. 

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.